The company attempted to use organic material from the early stages in the plants’ lives in order to grow more product, opposed to the traditional method of trimming bits of already growing plants in a process called “cloning.” (Source: “Failed marijuana experiment slams Organigram earnings,” MarketWatch, July 16, 2019.). Earlier this year, Canopy Growth's (NYSE:CGC) CEO was shown the door because of higher-than-expected losses, and shares of Aurora Cannabis (NYSE:ACB) fell sharply after the company failed to deliver results as strong as it had previously guided for. This was a stark departure from the CA$2.8-million profit ($0.03 per share) the company saw in the period a year prior. Analysts have an average target price of $8.24 for OGI which is 125% above the current trading pric at writing. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. Strong brand recognition is also fueling to the OrganiGram fire. All rights reserved. The Motley Fool Canada » Cannabis Stocks » Why Did OrganiGram Holdings Fall 20% Yesterday? Although lower-than-expected sales growth isn't a good thing, investors should keep in mind that only about 20% of Canada's CA$6 billion marijuana market is currently conducted legally. NV5 Global Inc: Why This Stock Could Surge in COVID-19 Recovery, Health Catalyst Inc: Why This May Be the Perfect Healthcare Stock Regardless of Election. OGI stock had a bumpy ride following its quarterly report release, but the company remains one of the strongest in the marijuana market today. Copyright © 2020. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. It has seen over 80% growth over the past year, and despite a rocky recent performance, it still finds itself on the positive side of things—an impressive feat, considering that much of the pot industry has experienced a downturn. The cannabis industry is going through some growing pains. At this point, OrganiGram Holdings stock is in a very enviable position: small and flexible enough to see big gains while also having the size to be stable through these difficult market times. The factors behind OrganiGram's lower-than-expected Q4 numbers were largely in line with what the rest of the industry has been talking about. Not to alarm you, but you’re about to miss an important event. The combination makes it truly one of the more impressive buys in an industry full of them. OGI also has a strong reputation for production efficiency. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why OrganiGram Shares Tumbled 13.6% Today @themotleyfool #stocks $OGI $ACB $CGC $HEXO, Got $3,000? © 2020 The Motley Fool Canada, ULC. The cannabis derivatives market swings into full gear in mid-December. Please read the Privacy Statement and Terms of Service for more information. OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI) has been one of the more interesting companies in the cannabis space for quite …, At the end of April, OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI) filed all the necessary paperwork with the NASDAQ in hopes of uplisting to the major exchange. There has been quite the sell-off of OrganiGram Holdings (TSXV:OGI) (OTCQX:OGRMF) stock since the beginning of this week. The Motley Fool recommends OrganiGram Holdings and OrganiGram Holdings. OrganiGram Stock: What Uplisting to the NASDAQ Really Means, Curaleaf’s Select Brand Announces Partnership with Jim Belushi and Belushi’s Farm, WeedMD and Starseed Medicinal Launch Combined Medical Sales Marketplace with Expanded Cannabis Product Offerings, Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets, The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020, Ventura Cannabis (VCAN) and Vibe Bioscience (VIBE) Close Cathedral Sale. Enter your email address below to get started now, and join the other thousands of Canadians who have already signed up for their chance to get the market-beating advice from Stock Advisor Canada.